BioTech IQ
  • Home
  • Podcast
  • Hiring?
  • Blog
  • Contact
Select Page
Going Beyond The Current Standard Of Care For Anxiety, Depression, And CNS Disorders With Shawn Singh

Going Beyond The Current Standard Of Care For Anxiety, Depression, And CNS Disorders With Shawn Singh

by Ammon Rivera | Jul 22, 2022 | Podcast

  Social anxiety disorder is the third most common mental health disorder. Over 23 million Americans alone are affected by it. This disorder can continue to grow into depression and drug abuse, so it’s very important to catch it early so it can be stopped....
Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper

Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper

by Ammon Rivera | Jul 15, 2022 | Podcast

  Companies in the biotech space are making contributions to help find a cure for cancer. Today’s guest is no exception. In today’s episode, Ammon Rivera sits down with Daniel Teper, Co-Founder and CEO of Cytovia Therapeutics, to talk about the unique technology...
Cell Cycle Therapy: Understanding The Cell Cycle Biology To Treat Cancer With Spiro Rombotis

Cell Cycle Therapy: Understanding The Cell Cycle Biology To Treat Cancer With Spiro Rombotis

by Ammon Rivera | Jun 10, 2022 | Podcast

  Cell cycle biology is key to understanding cancer. You have to hit the cancer cells early before they become smart and adapt. There is a stage in the cell cycle called mitosis. This is where, if done right, can cause cancer cells to suicide. This is where the...
Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?

Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?

by Ammon Rivera | May 27, 2022 | Podcast

  Have you ever thought about having replacement parts for your body? It sounds like science fiction, but it’s now as real as the eyes you’re using to read this, thanks to cell-based therapy. Brian Culley is one of the leaders in this field. He is the CEO of...
Global Tensions And Supply Chains And Their Effect On Biotech. Guillermo Morales, PhD, CEO Of Innoventyx

Global Tensions And Supply Chains And Their Effect On Biotech. Guillermo Morales, PhD, CEO Of Innoventyx

by Ammon Rivera | May 17, 2022 | Podcast

  The biotech industry has been bombarded with disruptions in recent years, from a global pandemic to rising global tensions. How are they dealing with the supply chain issues and how else has it impacted the industry? In this episode, Ammon Rivera sits down with...
Can Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhD

Can Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhD

by Ammon Rivera | Apr 29, 2022 | Podcast

  On this episode of BioTech IQ, Ammon Rivera interviews Robert Foster Pharm D, PhD, CEO of Hepion Pharmaceuticals. Robert brings 30 years of experience to this discussion and shares with us details of his background that led him to where he is today. We also...
« Older Entries
Next Entries »

Recent Posts

  • From Writing a Newspaper Column at Age 7 to Becoming a BioTech CEO
  • Biotech Chief People Officer Discusses How To Build Company Culture
  • Qualigen Therapeutics: Where It All Started And Where It’s Going With Founder And CEO Michael Poirier
  • Qualigen Therapeutics: How To Develop An Oncology Therapeutics Pipeline From A CMO’s Perspective With Tariq Arshad, MD
  • Qualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy Broidrick

Recent Comments

No comments to show.

Follow BioTech IQ 

  • Follow
  • Follow
  • Follow
biotech logo black

187 W Main St,
Suite 203
Lehi, UT 84043

Biotech IQ © Copyright 2022. All Rights Reserved